Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nissim Hay

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Mnk earmarks eIF4E for cancer therapyNissim Hay
Nature Reviews. Cancer|September 17, 2016
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Nissim Hay
Cancer Cell|September 20, 2005
The Akt-mTOR tango and its relevance to cancerNissim Hay
Journal of Breast Cancer Research|May 17, 2022
How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in miceNissim Hay
Trends in Endocrinology and Metabolism: TEM|October 16, 2010
Akt isoforms and glucose homeostasis - the leptin connectionNissim Hay
Biochimica Et Biophysica Acta|March 29, 2011
Interplay between FOXO, TOR, and AktNissim Hay
Cell Metabolism|September 3, 2008
p53 strikes mTORC1 by employing sestrinsNissim Hay
Genes & Development|August 18, 2004
Upstream and downstream of mTORNissim Hay, Nahum Sonenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapyVeronique Nogueira, Nissim Hay
Biochimica Et Biophysica Acta|September 20, 2011
PI3K-AKT-FoxO axis in cancer and agingGuri Tzivion, Nissim Hay
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Mnk earmarks eIF4E for cancer therapyNissim Hay
Nature Reviews. Cancer|September 17, 2016
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Nissim Hay
Cancer Cell|September 20, 2005
The Akt-mTOR tango and its relevance to cancerNissim Hay
Journal of Breast Cancer Research|May 17, 2022
How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in miceNissim Hay
Trends in Endocrinology and Metabolism: TEM|October 16, 2010
Akt isoforms and glucose homeostasis - the leptin connectionNissim Hay
Biochimica Et Biophysica Acta|March 29, 2011
Interplay between FOXO, TOR, and AktNissim Hay
Cell Metabolism|September 3, 2008
p53 strikes mTORC1 by employing sestrinsNissim Hay
Genes & Development|August 18, 2004
Upstream and downstream of mTORNissim Hay, Nahum Sonenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapyVeronique Nogueira, Nissim Hay
Biochimica Et Biophysica Acta|September 20, 2011
PI3K-AKT-FoxO axis in cancer and agingGuri Tzivion, Nissim Hay
Pageof 12